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Introduction
Prostate cancer is the highest incidence cancer diagnosis for 
men worldwide, with approximately 35,000 men diagnosed 
with the condition in the UK each year (1). Despite rising 
detection rates via increased public awareness and prostate 
specific antigen testing, however, mortality has remained 
static (1). Consequently, increasing numbers of men are 
surviving long beyond the original diagnosis and experiencing 
the long-term effects of the disease and its treatment. 
Sexual dysfunction presents a particular challenge, with 
men and their partners experiencing deterioration in sexual 
functioning as a consequence of all treatment options. 
Surgery is known to result in erectile dysfunction (ED) (2), 
with recovery of function often occurring up to five years 
following treatment (2). Even nerve-sparing surgery 
impacts on sexual functioning (3), though less invasive 
surgical techniques are being championed to reduce impact 
on sexual and urinary function (4). ED is also a known 
treatment consequence of external beam radiotherapy 
and brachytherapy (5). Studies suggest that the overall 
impact on sexual functioning is likely to be underestimated 
in the quality of life (QoL) literature (in part due to the 
methodological limitations of fixed questionnaire scales) (6), 
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and emerge as a concern as men enter follow-up (3). 
Despite these data, the impact of prostate disease on sexual 
functioning has been described as an outcome that has been 
neglected by urologists (3,7). Research focus and clinical 
practice developments have tended to concentrate on the 
use of assistive technologies: primarily pharmacological 
interventions, to help some men achieve more normative 
erectile function (8). However, such responses are limited 
as they may lack integration with couple-focused strategies 
which, if delivered effectively, could enhance the success 
of biomedical interventions. Further, prostate cancer is 
often portrayed as a disease of individual men (9), whereas 
research has increasingly pointed to the shared nature of 
the experience within a unique couple dynamic (10-13), 
with evidence demonstrating poorer sexual functioning 
when compared to the general population (11). Studies 
have also started to emphasise partners as ‘unpaid/
unrecognised carers’, indicating the need for a further 
precedent to appreciate and address their needs in order 
to support and sustain their physical, emotional and 
caregiving role (11).
Despite the growth in prostate cancer research, the 
majority of studies in prostate cancer have focused on the 
impact of management of ED as an iatrogenic consequence 
of androgen therapy or radical prostatectomy (14). The 
impact on partners has been a more recent development 
but attention is being concentrated on this issue (15,16). 
In the latter study the issue of distress in female partners 
was examined and revealed the shared nature of the cancer 
event, and the need to reassess the situation once prostate 
cancer had been confirmed and to accept the challenges, 
threats and losses facing them, manage changes and create a 
meaningful intimate and social life (15). Furthermore there 
have been questionnaire studies exploring how prostate 
cancer couples rate each other’s coping and distress. One 
study demonstrated that higher QoL, in both groups, was 
associated with higher education levels, lower avoidant 
coping, and higher relationship satisfaction (17).
The present study sought to document the intimate 
experiences of men and their partners post-treatment, 
focusing particularly on qualitative accounts of the impact in 
relation to sexual functioning and how these concerns were 
managed between themselves, and discussed in the clinic. 
Materials and methods
In-depth interviews were conducted with participants 
recruited from two inner-city English hospitals. The study 
received ethical approval from the local NHS Research 
Ethics Committee. 
Subjects
Interviews were conducted with respondents as couples, 
or individuals, depending on their stated preferences, 
recognising the benefits and constraints of individual 
versus dyadic interviews. Of the 18 participants, six couples 
agreed to a joint interview. Two couples provided individual 
accounts, and two men agreed to participate only without 
their partner.
Maximum variation sampling (18) encouraged a purposively 
heterogeneous demographic mix (Table 1), that included 
a diverse group of men with experience of a range of 
treatment options. Participants’ ages ranged from 34 to 78 
years and all were at least 2 years post surgery or radiation 
therapy, some were still on hormone therapy. The majority 
Table 1 Socio-demographic and medical data of participants
Sample characteristic N [%]
Ethnicity (n=18)
White British and White Irish 10
African Caribbean, Australian, Chinese, Greek,  











The men’s treatment (n=10)
Prostatectomy 4 [40]
Hormone therapy 1 [10]
Radiotherapy/HIFU 1 [10]
Combination of two therapies 3 [30]
Combination of three therapies 1 [10]
Stage of treatment
On treatment (hormone therapy) 2
Follow-up 8
HIFU, high-intensity focused ultrasound.
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of patients and partners were classified as White British, 
with the remaining 44% drawn from minority ethnic 
backgrounds including Greek, African Caribbean, Chinese, 
North African and Filipino. The sample was also purposively 
devised to ensure men had completed treatment at least 
two years before and were undergoing follow-up care at the 
time of the study. This allowed them, and their partners, to 
consider the enduring impact of cancer treatment. 
Inclusion & exclusion criteria
Inclusion criteria were men (and their partners where 
possible) willing to provide written consent and living with 
a diagnosis of prostate cancer who have had experienced 
external beam radiotherapy, prostate surgery or androgen 
therapy at least 2 years previously. This was to ensure that 
short-term treatment effects were minimised and some 
adaptation to their situation had occurred. Exclusion 
criteria included men less than 2 years out of treatment, 
those unable/unwilling to provide written consent or those 
with co-morbidities that were likely to impact significantly 
on their experiences. Advice was sought from medical staff 
about the study and its aims, assistance with access to men 
was provided by Nurse Specialist or Consultants.
Procedure & interview focus
Interviews were carried out in participants’ homes. They 
were intentionally exploratory in nature and all participants 
were invited to reflect on the cancer experience and its 
impact on their sex lives. They were advised at the time of 
recruitment that we wanted them to be as honest as possible 
and to use language that felt comfortable. 
An experienced researcher with a background in mental 
health and communication skills education undertook all 
interviews (SML). The interviews followed a conversational 
style using series of prompts such as ‘Can you tell me 
about the impact of prostate cancer on your relationship?’; 
‘How has this been experienced in terms of your sexual 
relationship?’; ‘How has your partner been affected by this 
experience’; ‘Can you tell us how this was dealt with by the 
health care professionals you have met?’. 
Interviews were then transcribed in full and checked for 
accuracy by two members of the team (DK & SML). 
Coding
Analysis proceeded with a full reading and discussion between 
two of the researchers to support the organisation of the 
interview transcripts. Codes were developed in the process of 
defining categories and identifying recurring and less usual 
themes. Thus, categories were formulated and overarching 
themes were identified (for example gendered aspects of 
the disease, the shared nature of the event), to describe and 
explain the couples’ and individuals’ experiences of prostate 
cancer outcomes. Data were coded and comparisons made 
across the transcripts about couples’ experiences since 
treatment, expectations and views of current service provision 
regarding recovery following prostate cancer treatment. This 
approach allowed the interviewer to remain focussed on what 
might help people in their situation, as well as illuminate the 
experience they have been through as a couple (19). 
Results
Four categories were identified within the transcripts 
that represented core components of intimacy and sexual 
recovery following prostate cancer treatment. These related 
to social influences and language used to describe the loss or 
recovery of sexual activities; discussing sexual activity with 
clinicians; the clash of individual versus couple paradigms 
of prostate cancer recovery and the re-integration of sexual 
activities into the relationship.
Social influences and language used in relation to sexual 
expression
Social influences and language emerged as recurring 
features in these interviews. This included, for instance, 
the use of metaphors, the vocabulary chosen to describe 
sexual dysfunction or activity, and inherent culturally-
derived expectations. There was evidence of frequent use 
of metaphors by both patients and partners. One partner, 
who found it difficult to express her frustration at her 
husband’s ED, and his complacency towards it, related her 
dissatisfaction in terms of “I’m dying… of thirst… of food” 
and “A little cuddle?, No! I’m starving” (Female partner, 
couple 9, post surgery). 
The expression “Rome wasn’t built in a day” (Female 
partner, couple 8, post radiotherapy) was also used to 
demonstrate a partner’s understanding of the gradual 
process involved in resuming sexual expression after 
prostate cancer treatment. Much of the language used by 
participants referred to ED and the failure of achieving an 
erection, for example: “it was floppy”, “we had a small, fairly 
flaccid penis”—it was noteworthy that women would often 
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speak of the problem in joint terms rather than just the 
man’s. More technical terms such as “masturbation” and 
“ejaculation” were used during the interviews rather than 
colloquial or slang terms. In social terms, this might be a 
sign of not seeming to appear crude or disrespectful in the 
interview context but, does raises an important point about 
the type of language that may be considered acceptable in 
clinical situations. 
Underpinning the use of these terms were cultural 
expectations in relation to sexual dysfunction experienced 
predominantly from the patients’ perspective. The focus 
was usually on problematic erectile function. One of the 
men had asked his male friends about failing sexual ability. 
Although he had very strong sexual desire, his “orgasm, 
erection does not last for a long time, one to one and a half 
minutes… not very strong” (Patient, couple 3, post surgery). 
He was prescribed a PDE5 inhibitor and claimed that he 
didn’t want pleasure for just himself but for his wife as well, 
and felt that he was the one who should “fix this problem”. 
The expectations of all patients (except two) was to resume 
full sexual activity as soon as practicable and this appeared 
to be a higher expectation than that held by partners who 
expressed the belief in taking things at a more steady pace.
One female partner explained this eagerness to please and 
to meet perceived expectations within the sexual relationship: 
“He was too anxious to try to please me and nothing would 
happen at all and I would say, ‘Don’t be silly, you wait and see 
another couple of months will be fine and give it time and don’t 
jump the gun too quick. You know, you’re not ready yet’. After 
a while it was fine. I think it was a natural reaction.” (Female 
partner, couple 1, post surgery).
At times, the choice of language of sex and intimacy 
could become a source of discomfort and tension within the 
medical consultation. The following quotation illustrates 
how one patient was asked to modify his language:
“Do you remember he said ‘Have I had sex?’ and I said 
‘Oh I’d had a shag twice’ and he said ‘Don’t talk like that’ or 
something…so I said ‘Oh well better call it sexual intercourse.’” 
(Male patient, couple 4, post surgery).
This articulation of clinician discomfort is framed 
as related to the language that the patient chose to use, 
rather than avoidance of talking about sexual topics more 
generally. This does, however, signpost potential tensions in 
talking openly about sex and intimacy in a language which 
the patient, partner and clinician are comfortable with.
There were instances of remarkable frankness during 
data collection—one Arab couple spoke of their intimate 
relationship very openly with young children climbing 
over them, another couple was interviewed as they lay on 
their bed together and the interviewer sat beside them. 
There was no sense of awkwardness about these situations; 
perhaps because the interviewer was comfortable with the 
discussion herself and so the participants felt able to vent 
their concerns and experiences. The social context within 
which disclosure takes place, therefore, may need to be 
considered. The home setting for this study seems to have 
encouraged openness—more so than had been achieved in 
clinical settings. 
Discussions with clinicians about sexual activity
Talking with clinicians about intimacy and sex—either in a 
positive or a negative sense—was a common theme within 
these interview data. This included reflections on treatment 
decision-making, the range of topics that were discussed, 
and the ways in which clinicians communicated whether 
sex was an acceptable and appropriate topic for discussion 
within oncology outpatient clinics. Information about sexual 
functioning and the likely changes post-treatment were an 
expressed interest of both patients and partners.
Health care professionals in outpatient clinics had 
communicated their understanding of the expected pattern 
of sexual recovery of patients and their partners: 
“We found … (the nurse practitioner) very good and explained 
about sex life. Her information helped a lot.” (Female partner, 
couple 1, post surgery).
Participants reflected on who had initially raised the 
topic of sex and concerns about ED:
Female partner: (My husband’s) erection was getting worse 
and worse... Now this isn’t something he brought up with 
(consultant) really.
Patient: (Consultant) asked me about it I think, as opposed to 
the other way around. 
Partner: He (my husband) didn’t really want to bring up that 
topic, did you? (Couple 2, post surgery).
Couples felt that talking about sex and intimacy was an 
important topic; requiring a senior clinician to give the 
topic the gravitas it deserved: 
“I think you have to have a doctor or a nurse or somebody 
who’s in a senior position who is quite sympathetic and knows how 
to be able to sit down and talk to a couple, because I think that’s 
very important really, you know it’s no good like the couple going 
in and seeing the consultant or the doctor or the nurse and they’re 
just flippant with them, they don’t explain things.” (Partner, 
couple 1, post surgery).
The majority of this sample did not feel that clinicians 
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had discussed sexual functioning well, and reported that 
such concerns were not always appropriate to share with 
friends/family:
“Unconsciously, I was really scared. I wish I’d had somebody like 
you (the researcher), what I would call a professional that’s, because 
it’s not something that you can talk about to close friends because, 
it’s too intimate.” (Partner, couple 6, androgen therapy).
Limited opportunities were offered to individuals or 
couples to talk about their psychosexual needs; this was felt 
to be a considerable constraint of current service delivery: 
Interviewer: Do you think that your psychosexual needs had 
been met in terms of the care that you received after the treatment?
Patient: Well once I went off the hormonal drug, there was 
no, shall we say, counselling or anything.
Interviewer: Did anyone talk to you about it or mention it or 
was it...?
Patient: No, no, my oncologist in [another country] did say to 
me that once you’re off the drug things will get back to normal but 
what he didn’t tell me was how long, it was only after I asked a 
question when I got the result that it will take a year to eighteen 
months for your body to eliminate all the effects of the [treatment], 
that was all I was given. (Patient, couple 6, androgen therapy).
Thus, while some information was provided, all of 
the participants felt that this stopped short of what they 
required to enter psychological recovery feeling adequately 
prepared for the timeframes over which physical recovery 
might take place. 
At times, discussions about sex included directives about 
what sexual activities were permissible at specific time 
points during recovery. A minority of participants had 
offered leaflets about sexual functioning, and aids to EF 
recovery such as vacuum constriction devices, while others 
had not been given advice but felt that this would have been 
extremely helpful. Rarer in the data was an expression that 
discussions of ED and incontinence had guided treatment 
decision making. The following participant describes 
photo dynamic therapy (PDT) and high-intensity focused 
ultrasound (HIFU):
“He said ‘What are you going to do?’ so I said ‘I got two choices I 
need to do the PDT again... or I can do the HIFU and I don’t want 
to do the conformal, I don’t want to do the surgery or any others’ 
I said because ‘I don’t want to be impotent or incontinent and 
everything else’. And what I said was ‘Is it better to have ten years 
of fun or fifteen years of hell?’” (Patient 5, post radiotherapy).
Meanwhile, other patients were given so little information, 
that they were uncertain when they could resume regular 
sexual activity, without putting their health in danger:
“The thing that stopped me [having sex] was, first of all I 
was, I couldn’t pee at all so I had to put the catheter in every few 
hours, and, we saw there was lots of blood coming out and this 
sort of thing...so I thought maybe I’d do myself some damage and 
that’s why... So it was a ‘damage I might do to myself’ scenario, 
and nobody said to me in the hospital, ‘Oh you can have sex 
whenever you feel like’ they just said ‘You’ve got to wait a week or 
a month.’” (Patient, couple 4, post surgery).
In other instances pre-treatment discussions of sexual 
functioning continued post-treatment, with some physicians 
asking about erectile functioning at follow-up appointments. 
The following participant reflects on how he was asked to 
describe his erections, following treatment:
“And I said ‘Oh it’s’, I said ‘the first time was a bit soggy... 
And the second one was okay’ I said ‘but only half an hour.’” 
(Patient, couple 4, post surgery).
The importance of transparent discussions with 
clinicians is underlined by the paucity of opportunities some 
participants seem to have had to talk about their sexual 
functioning elsewhere. 
At an individual couple level, there were also examples of 
where the private impact had probably not been appreciated 
by health professionals. One of the members of the two gay 
couples who took part spoke of how his partner had become 
‘very fat after the hormone therapy’ and said:
‘This was very hard to come to terms with, a fattish old man.’
His partner does not now ejaculate but:
‘Joint ejaculation had been very important to us, now he says 
I’m coming, I’m coming!, but there’s no visible signs.’ (Couple 6, 
androgen therapy).
The man also spoke of feeling guilty at finding his 
partner unattractive since hormone therapy but had 
felt unable to discuss this—certainly not with a health 
professional. He also had not been aware that it was possible 
for a man to have a powerful but dry orgasm without a full 
erection; this learning had been experiential rather than 
anything given to the couple as an information package 
associated with the treatment choices.
Another man spoke of having had erections and sexual 
dreams leading to orgasms in the post-surgical period 
in hospital. This had not been disclosed to staff but his 
attitude to this had been rather accepting and he described 
professionals doing such work in a matter of fact way: 
“If you go to the butcher he know how to cut meat, if you go to 
the mechanic he fixes your car, so it’s your job…’. (Patient 6, post 
surgery).
Regarding his erections and his sexual recovery, however, he 
spoke of masturbating into a cloth after surgery due to it being:
 ‘Bloody and so as not spread germ.’
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An individualistic model of care
Partners often reported feeling excluded from the events 
relating to the cancer and its impact. For instance, shortly 
after diagnosis one of the partners recalled: 
“I would have liked, just once in a while, for the consultant to 
say, “How is your wife getting on? I really feel out of it and the fact 
was of course, I was affected.” (Partner, couple 2, post surgery).
Partners were rarely asked during clinics about their 
own needs in relation to the effects of the diagnosis and 
treatment outcomes. Thus, despite the sexual consequences 
of treatment having had a clear impact on the partner, 
they were rarely made to feel they had a genuine 
contribution to make to the medical consultation. The 
following excerpt illustrates this position of feeling under-
supported, particularly in the context of being in a same-sex 
relationship: 
Interviewer: Did they ask you, questions in terms of you 
know, were you okay?
Partner: No they never did, they were very nice but I think 
the… medical establishment in general is still rather formal. 
Interviewer: There’s no guidance, for same sex couples?
Partner: No, that’s right, and that really would have been 
very helpful. (Partner, couple 6, androgen therapy).
Some couples told the interviewer that they had not 
talked with each other about sexual concerns either before 
or after treatment:
Interviewer: Now did you talk about this before the operation?
Partner: No we didn’t actually. (…) I was very patient, 
because I think you have to be like that, you can’t just like click 
your fingers and everything’s going to come back to normal 
because it’s a big operation and he was very ill and it’s just 
basically if you love somebody enough it’s just, you just must sort 
of have patience and wait and then everything is fine. (Female 
partner, couple 1, post surgery).
The above extract indicates that although the clinician 
had talked with him and his partner about sexual concerns, 
this did not mean that the couple would necessarily talk 
about it further together. 
Re-integrating sex into the relationship
Couples found their own harmony in living with enduring 
changes such as moderate or severe ED and reflected on 
this with the interviewer: 
“The only way it’s affected my sex life is not getting an 
erection, to begin, though now that’s not a problem now.” (Patient, 
couple 1, post surgery).
A further interviewee reflected on changes in erectile 
functioning as he recovered from treatment:
‘Well it wasn’t really there because, there is no erection you know, 
as strong as I want it to be. (Patient, couple 3, post surgery).
Participants indicated the importance of regaining sexual 
functioning, with one man stating that he yearned for sex 
before his physical capability returned: 
“I was dying for some sex” (Male, couple 4, post radiotherapy).
Couples discovered that although penetrative sex may 
not be possible, other forms of intimacy and sexual activity 
were still available, and again the issue of orgasm without 
full EF was mentioned:
“One thing that I picked up on, which I thought was quite 
extraordinary was that you can have an orgasm with a flaccid 
penis.” (Partner, couple 2, post surgery).
For one man, although he regained erections very 
quickly after surgery, however this was not something his 
wife was aware of. Indeed, several years after treatment he 
was still sexually active, but not with his wife. The following 
quotation was also used above to illustrate pre-cancer 
relationships, but speaks equally powerfully to this sense of 
(re)integrating sex into current lifestyle choices:
“Well she (wife) will believe, and she does still believe it, that, 
I am er...you know, I cannot make love. She accepted it...that the 
penis it never gets hard.” (Patient 5, post radiotherapy).
Discussion
The final quotation above may reveal one of the reasons 
why some professionals, who may be under time pressures 
in clinical situations, find the discussion of sexual 
dysfunction a challenging topic. Such conversations bring 
them closer to the social and psychological complexities of 
people’s lives in ways that go beyond the traditional focus of 
the biomedical model. By adopting a qualitative approach to 
this study we were exposed to aspects of the couple’s sexual 
lives which would have not been revealed by questionnaire 
methods. However, both approaches have a role to play to 
reveal the needs of larger samples of couples across different 
disease trajectories.
Although only one person in a partnership experiences 
cancer, these data clearly indicated that the disease and 
its treatments also impacts on the partner. There is 
evidence that adjustment to ED takes time, but is a highly 
significant event in couples’ lives following prostate 
cancer. Its importance should not be under-estimated (20). 
Consequently, there is not only a need for patient-centred 
care, but also relational models of care, whereby side-effects 
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are recognised to impact on both members of a partnership 
(for example ED, or lack of ejaculation). Supportive care is 
therefore important for both patient and partner but must 
be tailored using language that is appropriate to the context 
of their lifestyles and expectations (3). 
A relational approach to couple-focused support will 
take into account an understanding of illness impact that 
extends beyond the individual (patient-centred) bio-medical 
model. Instead it views cancer as a life-changing event that 
affects not just individuals, but everyone in one’s intimate, 
and wider, sphere of relationships. To truly understand and 
address the wider impact of prostate cancer, it is vital that it 
is accepted as a condition affecting both the patient and those 
with whom he relates. Importantly these relationships may 
be spousal, casual or committed (or multiple combinations 
of these possibilities). The danger for the professional is to 
make assumptions.
These data suggest that health professionals should be 
supported to develop a more nuanced understanding of 
how best to work with couples in the post-cancer situation. 
There are clear practice implications for professionals in 
being able to provide care for patients and partners in a 
morally neutral way, while maintaining confidentiality 
within and between the two (or more) parties in sexual 
relationships. Consequently, HCP education should 
explore culturally held assumptions related to aspects of 
social difference such as age, gender and sexual orientation. 
Beyond this ideological level, healthcare professionals 
should also receive practical support to raise sexual 
functioning and intimacy within clinical conversations, so 
that these topics are given adequate gravitas. In addition 
to the bio-medical model of resuming sex after-treatment 
using medication, assistive technologies and sex toys (20), 
there should also be an emphasis on the development of 
couple-working skills and disclosure of worrying symptoms; 
such as the impact of ED. Clinical trials are exploring ways 
to support men and partners after therapy (21,22).
Finding a vocabulary for these clinical conversations is 
critical, with the patient, partner and health professional 
finding a mutually acceptable lexicon for discussing 
sex and intimacy. This may include shifting between 
medicalised language and lay terms to accommodate 
varying levels of (dis)comfort at talking about sexual/
intimate issues (19). 
We must also acknowledge the limitations of this 
small, heterogenous sample. In qualitative studies the 
aim is to obtain depth of insight from smaller numbers. 
However, we also wanted to include as mixed a group 
as possible.  Whilst we can offer insights here we 
recommend larger scale studies are needed, using mixed 
research methods. 
To return to the original impetus for this study about the 
impact of prostate cancer on couples, we are reminded of the 
fact that sexual expression is one of the most fundamental 
of human pleasures. It allows people to engage intimately, 
to derive pleasure from each other’s body and reinforces the 
bonds that exist—and that become so important—when a life 
threatening illness is diagnosed. When we set out to cure or 
control cancer but, in the process, leave individuals unable to 
experience the pleasure of sexual intimacy then we must ask if 
we have really promoted their wellbeing. To some individuals 
this outcome may be very acceptable, whereas to others they 
may be left with a sense of regret. 
Qualitative research methods can allow us insights into 
these issues and can reveal nuanced examples of the impact 
of cancer treatments. The primary message of this paper is 
that information and communication can help clarify what 
expectations might be acceptable, and achievable, and which 
are less likely. Previous research revealed that prostate 
cancer consultations, although focussing on the area of the 
body most associated with sexual function, did not always 
encourage the topic to be addressed. Instead the topic was 
most often raised by the patient, if it was at all, and some 
men (such as those with co-morbidities) were least likely to 
be asked about sexual concerns (19).
By not including this issue into routine practice we risk 
diminishing the importance of sexual function in the mind of 
patients and partners, and in doing so their anxiety may be 
magnified. Mitchell (23) captures this final sentiment well:
‘Sexual pleasure, is also relative, and is often as much a 
product of expectation, of the symbolic meaning of the act, and 
of the emotional and relational context as it is of the physical 
experience’ (p.60). 
This is a useful reminder as we engage in curative 
work with increasing numbers of men, and their partners, 
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